Clinicopathology observation of primary pulmonary sarcomatold carcinoma: 15 cases
10.3760/cma.j.issn.1001-4497.2019.11.003
- VernacularTitle: 15例原发性肺肉瘤样癌临床病理观察
- Author:
Yangyang SUN
1
;
Xiaoli ZHOU
1
;
Wenxian GU
1
;
Gengfang WANG
1
;
Wei GAO
1
Author Information
1. Department of Pathology, Changzhou NO.2 People's Hospital of Nanjing Medical University, Changzhou 273100, China
- Publication Type:Journal Article
- Keywords:
Sarcomatold carcinoma;
Lung neoplasma;
Spindle cell carcinoma;
Pathological characteristics
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2019;35(11):649-654
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical pathological feature of primary pulmonary sarcomatold carcinoma and to make a further understandine of the disease.
Methods:Data including clinical manifesation, pathological findings, molecular detection and immunophenotyping with pathologically confirmed primary pulmonary sarcomatold carcinoma was retrospectively analyzed.
Results:15 patients with PPSC were identified(13 men and 2 women, age ranged 56-76 years, median age 66 years). The tumor were located in the left lobus superior(8 cases), lobus inferior(6 cases), and the right lobus medius(1 case). The main clinical symptoms was cough, sputum, bloody sputum, chest pain. Among the 13 males, 10 had smoking history of more than 30 years, and 2 females had no smoking history. All cases presented with a spheroid solid lung mass. All tumor showed mild enhancement similar to that of the surrounding musculature after contrast enhancement, and inhomogeneous central low-attenuation areas were seen in 15 patients. Pathological pattern: 6 cases spindle cell carcinoma, 4 cases pleomorphic carcinoma, 2 cases giant cells carcinoma, 2 cases carcinosarcoma, 1 case pulmonary blastoma. The tumors were composed of both carcinomatous and sarcomatous elements. Immunohistochemistry showed that CK was all positive, EMA was positive in 7, VIM was positive in 10 of 15 cases.10 patients were tested for common related genes of lung cancer, 4 patients had MET14 jump mutation, EGFR L858R gene mutation occurred in 3 cases, KARS G13D gene mutation in 2 cases, and BRAF V600E mutation in 1 case. All 15 patients underwent lobectomy, 13 underwent adjuvant chemotherapy, and 6 underwent local radiotherapy. Postoperative follow-up was 8 to 50 months, 3 cases were lost, and 4 cases were survival 3 years after the surgery.
Conclusion:Pulmonary sarcomatold carcinoma is a rare histologic subtype of non-small cell lung cancer. Compared with other NSCLC, there is no special clinical and imageing characteristics. Its definite diagnosis relies on postoperative pathological analysis and immunohistochemical staining, and PSC needs to be diatinguished from a variely of disease. PPSC is more aggressive and poor prognosis.
